02 July 2024 Recce Pharmaceuticals Reports Positive Data From Phase I/II UTI/Urosepsis Rapid Infusion Clinical Trial of RECCE ® 327 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post